Clinical trials
Cytokine Release Syndrome trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 4 |
| Recruiting | 2 |
| Completed | 1 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Institute of Hematology & Blood Diseases Hospital, China | 2 |
| Chinese PLA General Hospital | 1 |
| Lin Chen | 1 |
| Liping Dou | 1 |
| Sichuan Provincial People's Hospital | 1 |
| The Children's Hospital of Zhejiang University School of Medicine | 1 |
| Tongji Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cytokine Release Syndrome | 8 |
| COVID-19 | 2 |
| Sepsis | 2 |
| Autonomic Nervous System Diseases | 1 |
| Hematologic Neoplasms | 1 |
| Leukemia, Myeloid, Acute | 1 |
| Lymphohistiocytosis, Hemophagocytic | 1 |
| Multiple Organ Failure | 1 |
| Neoplasm, Residual | 1 |
| Neoplasms, Plasma Cell | 1 |
Trials
Showing 51 to 8 of 8. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.